Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cepharanthin for oral lichen planus
jRCTs051220130Active, not recruiting
- Sponsor
- Nara Medical University
- Start
- Dec 2022
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of cepharanthine in oral lichen planus (OLP) (2 arms), sponsored by Nara Medical University. Primary endpoint: Change in pain intensity when drinking room temperature water from baseline to week 8. Started Dec 2022; status: active, not recruiting.
02
Drugs
cepharanthine
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on jRCTs051220130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051220130.